AstraZeneca Esopreze 20 mg

Esopreze is a prescription medication containing esomeprazole, used primarily to treat conditions like gastroesophageal reflux disease (GERD). The brand is part of the AstraZeneca portfolio, which has a long-standing history in gastrointestinal medicine, famously developing Nexium. Esopreze serves as a specific branded version or generic equivalent marketed in various regions including Australia, as evidenced by the AUST R number on the packaging.

AstraZeneca is one of the world's largest pharmaceutical companies, formed through the merger of Sweden's Astra AB and the United Kingdom's Zeneca Group. While the product is marketed globally, manufacturing typically occurs across a network of international facilities in Europe, Asia, and North America depending on the supply chain for the specific market. The ultimate ownership remains with AstraZeneca PLC, headquartered in Cambridge, UK.